Gupta Ambika, Agarwala Anuja, Kalaivani Mani, Malik Rohan, Sharma Rajni, Kabra Madhulika, Gupta Neerja
Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
J Pediatr Gastroenterol Nutr. 2025 Jan;80(1):151-162. doi: 10.1002/jpn3.12391. Epub 2024 Nov 1.
Glycogen storage disorders (GSD), inherent disorders of carbohydrate metabolism, feature hypoglycemia as a hallmark. Normoglycemia and glucose monitoring are pivotal in disease management. Conventional glucometer-based monitoring may overlook hypoglycemic trends. This study assesses glycemic control in Asian Indian GSD children using continuous glucose monitoring (CGM) and its role in facilitating dietary adjustments.
A pre-post study enrolled molecularly confirmed GSDI, GSDIII, GSDVI, and GSDIX patients for baseline dietary compliance and CGM-based glycemic status evaluation. Hypoglycemic patients were stratified into diet-compliant and diet-noncompliant groups. Noncompliant patients received dietary reinforcement; compliant individuals underwent dietary adjustments. Repeat CGM (rCGM) was performed 6 weeks to 6 months postadjustments. Clinical and metabolic parameters were re-evaluated at 6 months.
Of the 20 patients assessed at baseline, 11 were diet compliant. Six among these exhibited hypoglycemia, prompting diet adjustments. Among nine noncompliant patients, eight experienced hypoglycemia and received diet reinforcement. rCGM in 10 patients (five GSDI, three GSDIII, and two GSDIXc) showed a significant reduction in hypoglycemia duration in all. An improvement in height and body mass index was observed in all GSDI and GSDIII patients. Triglyceride levels, raised at baseline in two GSDI and one GSDIII, showed a substantial decline in one GSDI patient. Hepatic transaminase levels decreased in both GSDIXc patients. Plasma lactate levels decreased in all GSDI patients.
CGM is an efficacious adjunct in the personalized management of hepatic GSD patients, in the Asian Indian population. The study also underscores the need for long-term follow-up to determine the role of glycemic management in growth, general well-being, and metabolic control in the GSD subtypes.
糖原贮积病(GSD)是碳水化合物代谢的先天性疾病,以低血糖为主要特征。血糖正常和血糖监测在疾病管理中至关重要。传统的基于血糖仪的监测可能会忽略低血糖趋势。本研究使用连续血糖监测(CGM)评估亚洲印度裔GSD儿童的血糖控制情况及其在促进饮食调整中的作用。
一项前后对照研究纳入了经分子确诊的GSDI、GSDIII、GSDVI和GSDIX患者,以评估基线饮食依从性和基于CGM的血糖状态。低血糖患者被分为饮食依从组和饮食不依从组。不依从的患者接受饮食强化;依从的个体进行饮食调整。在调整后6周至6个月进行重复CGM(rCGM)。6个月时重新评估临床和代谢参数。
在基线评估的20例患者中,11例饮食依从。其中6例出现低血糖,促使进行饮食调整。在9例不依从的患者中,8例出现低血糖并接受了饮食强化。10例患者(5例GSDI、3例GSDIII和2例GSDIXc)的rCGM显示低血糖持续时间均显著缩短。所有GSDI和GSDIII患者的身高和体重指数均有所改善。2例GSDI和1例GSDIII患者基线时甘油三酯水平升高,1例GSDI患者的甘油三酯水平大幅下降。2例GSDIXc患者的肝转氨酶水平均下降。所有GSDI患者的血浆乳酸水平均下降。
在亚洲印度裔人群中,CGM是肝脏GSD患者个性化管理的有效辅助手段。该研究还强调了长期随访的必要性,以确定血糖管理在GSD各亚型的生长、总体健康和代谢控制中的作用。